Atlas Trials

A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder

Clinical trial NCT07177677 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07177677
Sponsor
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2025-09-30
Primary completion
2026-12-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.